Side Effects of Stelara May Trigger Severe Cardiovascular Events: Study

The findings of a recent study link the side effects of Stelara to an increased risk of heart problems and strokes among high-risk patients who received the immunosuppressive drug.

Stelara (ustekinumab) is an injectable medication distributed by Janssen, a subsidiary of Johnson & Johnson, for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, Crohn’s disease and ulcerative colitis. It was first approved by the FDA in 2009, and already carries a warning that side effects may increase the risk of malignancies.

However, a study published last month by French researchers in the medical journal JAMA Dermatology warns that the monoclonal antibody targeting interleukin drug can cause severe cardiovascular events (SCEs) within a few months after initiating treatment among patients already at risk of heart problems.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The researchers conducted a case-time-control study using data from the French national health insurance database, which includes 66 million individuals. They looked at data on all patients who used Stelara between April 1, 2010 and December 31, 2016, classifying them according to their risk level for heart problems, and looking at the rate of cardiovascular events over a period of six months.

According to the findings, 9,290 patients were exposed to Stelara, with 179 of them experiencing heart problems. The events included 65 cases of acute coronary syndrome, 68 cases of unstable angina, and 46 strokes.

Patients categorized as having a high cardiovascular risk were more than four times more likely to have an SCE than those who did not take the drug. There was no sign of increased risk for those who were at a low cardiovascular risk.

“This study suggests that the initiation of ustekinumab treatment may trigger SCEs among patients at high cardiovascular risk,” the researchers concluded. “Although the study interpretation is limited by its observational design, these results suggest that caution may be needed in the prescription of ustekinumab to patients at high cardiovascular risk.”

In August 2016, the Institute for Safe Medication Practices (ISMP) issued a report warning that Stelara side effects were also linked to a 15-fold increased risk of cancer when compared to those taking the competing drug Otezla.

Psoriasis is a chronic skin disorder affecting about 7.5 million people in the U.S. and about 2% of the world’s population. It often appears as thick red patches of skin topped by white or silvery dead skin cells. It can also appear as lesions, pustules or inflamed skin. About 30% of those with the disorder develop psoriatic arthritis, according to the ISMP.

8 Comments

  • MelissaFebruary 13, 2024 at 8:53 am

    I’m 47 years old, female with crohns. I have had my second dose of stelara and I’ve had increased heart rate, irregular heart beat, angina daily, shortness of breath. I’m taking metoprolol to help calm my heart down. I worry this is because of my medication. I had no issues before taking Stelara.

  • BrennaDecember 14, 2022 at 1:57 pm

    I had my first infusion back in august and after fighting insurance for four months I finally got approved for the shots well I had my first shot last month and since starting it I’ve had shortness of breath and an ejection fraction of 45% at 26 years old.. now I need to see a cardiologist to find out if the damage is reversible.. heart failure at 26 was not in my future plans..

  • ScottNovember 25, 2022 at 7:56 am

    My wife had just taken I believe her 2nd self injected dose at home. Got a stomach virus end of Oct. and her heart stopped about 18 hours later at 56. Shocking!

  • AlmaNovember 20, 2022 at 3:53 pm

    I took my first infusion things went well I thought. Got my first shot at home . Went into heart failure. 17% ejection fraction. Severe yeast infection Bladder and urinary tract infection with blood .

  • MarkNovember 9, 2022 at 9:04 pm

    I am a 48 year old male who has been on stelara for over a year. I am 5’8 feet tall and weigh 170 lbs. I am active and have normal cholesterol levels. I recently had a stent put in an artery in my heart as a result of a 90 percent blockage. I am concerned about if this could have happened because of taking stelara.

  • KarleneOctober 27, 2021 at 6:59 am

    This drug should not be giving to people with underlying heart conditions ever.

  • KarleneAugust 26, 2021 at 11:16 am

    Could this drug contributed to my husbands heart attack ?

  • KarleneJuly 10, 2021 at 12:19 pm

    My husband had this drug and now he is dead due to a major heart attack.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.